Coronary interventions

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial

EuroIntervention 2015;11:180-187 published online ahead of print February 2014. DOI: 10.4244/EIJV11I2A32

Ming Kai Lam
Ming Kai Lam1, MD; Kenneth Tandjung1, MD; Hanim Sen1, MD; Mounir W.Z. Basalus1, MD, PhD; K. Gert van Houwelingen1, MD; Martin G. Stoel1, MD, PhD; Johannes W. Louwerenburg1, MD; Gerard C.M. Linssen2, MD, PhD; Salah A.M. Saïd3, MD, PhD; Mark B. Nienhuis4, MD, PhD; Frits H.A.F. de Man1, MD, PhD; Job van der Palen5,6, PhD; Clemens von Birgelen1,7*, MD, PhD
1. Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, The Netherlands; 2. Department of Cardiology, Ziekenhuisgroep Twente, Almelo, The Netherlands; 3. Department of Cardiology, Ziekenhuisgroep Twente, Hengelo, The Netherla

Aims: To investigate the prognostic value of coronary dominance for various adverse clinical events following the implantation of drug-eluting stents.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

coronary dominancepercutaneous coronary interventionperiprocedural myocardial infarctiontwente trial
Read next article
Long-term outcomes of angiographically confirmed coronary stent thrombosis: results from a multicentre California registry

Latest news